0001123292-15-001128.txt : 20150821 0001123292-15-001128.hdr.sgml : 20150821 20150821192422 ACCESSION NUMBER: 0001123292-15-001128 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150820 FILED AS OF DATE: 20150821 DATE AS OF CHANGE: 20150821 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: FIVE PRIME THERAPEUTICS INC CENTRAL INDEX KEY: 0001175505 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 260038620 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: TWO CORPORATE DRIVE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 415-365-5600 MAIL ADDRESS: STREET 1: TWO CORPORATE DRIVE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Knickerbocker Aron Marc CENTRAL INDEX KEY: 0001578766 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36070 FILM NUMBER: 151069731 MAIL ADDRESS: STREET 1: C/O FIVE PRIME THERAPEUTICS, INC. STREET 2: TWO CORPORATE DRIVE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2015-08-20 0001175505 FIVE PRIME THERAPEUTICS INC FPRX 0001578766 Knickerbocker Aron Marc C/O FIVE PRIME THERAPEUTICS, INC. TWO CORPORATE DRIVE SOUTH SAN FRANCISCO CA 94080 1 1 0 0 EVP & Chief Business Officer Common Stock 2015-08-20 4 A 0 75000 0 A 179965 D Represents shares of restricted stock, which will vest according to the following schedule: 50% of the restricted stock vests on September 1, 2016 with the remainder vesting on March 1, 2017, provided the reporting person remains employed by the company through each such date. Reflects the acquisition of 1,576 shares on May 15, 2015 pursuant to the Five Prime Therapeutics, Inc. 2013 Employee Stock Purchase Plan. /s/ Francis Sarena, Attorney-in-Fact 2015-08-21